Actinium Pharmaceuticals, Inc. (ATNM)
1.05
-0.02
(-1.87%)
USD |
NYAM |
Nov 20, 16:00
1.06
+0.01
(+0.95%)
After-Hours: 20:00
Actinium Pharmaceuticals Price : 1.05 for Nov. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2026 | 1.07 | 1.10 | 1.00 | 1.05 | 280911.0 |
| Nov 19, 2026 | 1.08 | 1.18 | 1.03 | 1.07 | 166511.0 |
| Nov 18, 2026 | 1.33 | 1.34 | 1.08 | 1.08 | 326840.0 |
| Nov 17, 2026 | 1.45 | 1.49 | 1.28 | 1.35 | 555005.0 |
| Nov 16, 2026 | 1.64 | 1.685 | 1.465 | 1.49 | 347947.0 |
| Nov 13, 2026 | 1.60 | 1.64 | 1.55 | 1.64 | 180622.0 |
| Nov 12, 2026 | 1.61 | 1.67 | 1.53 | 1.59 | 348115.0 |
| Nov 11, 2026 | 1.52 | 1.65 | 1.49 | 1.59 | 115534.0 |
| Nov 10, 2026 | 1.55 | 1.61 | 1.50 | 1.57 | 176420.0 |
| Nov 09, 2026 | 1.44 | 1.620 | 1.43 | 1.54 | 468368.0 |
| Nov 06, 2026 | 1.28 | 1.43 | 1.28 | 1.43 | 89253.00 |
| Nov 05, 2026 | 1.38 | 1.39 | 1.30 | 1.30 | 213040.0 |
| Nov 04, 2026 | 1.42 | 1.45 | 1.360 | 1.41 | 104261.0 |
| Nov 03, 2026 | 1.40 | 1.46 | 1.40 | 1.40 | 75845.00 |
| Nov 02, 2026 | 1.48 | 1.53 | 1.41 | 1.43 | 104580.0 |
| Oct 30, 2026 | 1.51 | 1.535 | 1.45 | 1.48 | 157720.0 |
| Oct 29, 2026 | 1.38 | 1.56 | 1.38 | 1.53 | 181671.0 |
| Oct 28, 2026 | 1.40 | 1.42 | 1.35 | 1.38 | 56558.00 |
| Oct 27, 2026 | 1.40 | 1.55 | 1.40 | 1.42 | 106954.0 |
| Oct 26, 2026 | 1.50 | 1.53 | 1.36 | 1.40 | 205864.0 |
| Oct 23, 2026 | 1.60 | 1.63 | 1.469 | 1.52 | 242011.0 |
| Oct 22, 2026 | 1.33 | 1.66 | 1.33 | 1.60 | 828818.0 |
| Oct 21, 2026 | 1.38 | 1.409 | 1.33 | 1.38 | 358233.0 |
| Oct 20, 2026 | 1.36 | 1.50 | 1.350 | 1.40 | 901051.0 |
| Oct 19, 2026 | 1.14 | 1.40 | 1.13 | 1.32 | 658396.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 17.11 |
| Alnylam Pharmaceuticals, Inc. | 143.82 |
| Anika Therapeutics, Inc. | 13.23 |
| Savara, Inc. | 4.26 |
| Arrowhead Pharmaceuticals, Inc. | 41.37 |
Price Related Metrics
| PE Ratio | 3.131 |
| PS Ratio | 0.9396 |
| Price to Book Value | 1.343 |
| Earnings Yield | 31.94% |
| Market Cap | 33.01M |
| Operating PE Ratio | 3.604 |
| Normalized PE Ratio | 3.131 |